ATLANTA, GA, Feb. 2, 2018 /PRNewswire/ - To ensure storage, handling, and protection of clients' electronic Patient Health Information (ePHI) meets and exceeds all government and industry standards, Medicat has made significant investments in its infrastructure and security framework. To substantiate that investment, Medicat has gone through the same third-party audit process as leading data centers in the country and has received Type 1 SOC 2 + HITRUST CSF, and Type 2 SOC 2 + HITRUST CSF Examinations.
BOSTON, Nov. 15, 2017 /PRNewswire/ - Banyan Software, a Boston-based company focused on acquiring, building and growing great enterprise software businesses, is pleased to announce the acquisition of Atlanta-based Medicat LLC, the leading provider of healthcare information technology and services to college and university student health clinics.
Medicat is the #1 patient health management system in the college health market with over 425 education clients serving 3.5 million students across 47 states and 3 countries. Medicat's fully-integrated single-database suite of products includes practice management with billing, Electronic Health Records, online patient portal, student self check-in, integrated text messaging, immunization compliance management, sports medicine, and counseling.
"Banyan offers Medicat a great long-term home" says Stacy Kottman, former CEO of Medicat. "Since 2005, we have built an outstanding team committed to serving our clients. We are confident that Banyan will continue this legacy while maintaining our company culture and product innovation."
ATLANTA, GA, June 29, 2015 - Medicat, LLC is pleased to announce enthusiastic attendees at the American College Health Association national conference raised $2,900 for the American Cancer Society.
January 9, 2015 - Medicat is pleased to announce it has achieved ONC HIT 2014 Edition Complete EHR certification, the most current federal standard available to EHR vendors (also known as ‘Meaningful Use Stage 2’ certification). Achieving this certification required rigorous testing by an approved third party to confirm all Clinical, Security and Interoperability criteria were met.